Peter J. Siska

4.5k total citations · 1 hit paper
43 papers, 2.8k citations indexed

About

Peter J. Siska is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Peter J. Siska has authored 43 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Peter J. Siska's work include Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Peter J. Siska is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Peter J. Siska collaborates with scholars based in Germany, United States and Austria. Peter J. Siska's co-authors include Jeffrey C. Rathmell, Marina Kreutz, Katrin Singer, Kathrin Renner, Rigel J. Kishton, Sivan Cohen, Jason W. Locasale, W. Kimryn Rathmell, Marc O. Johnson and Nancie J. MacIver and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Cell.

In The Last Decade

Peter J. Siska

40 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression

2016 409 citations Valerie A. Gerriets, Marc O. Johnson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter J. Siska Germany	21	1.3k	1.2k	1.0k	884	346	43	2.8k
Wei Yuan China	32	912 0.7×	1.2k 1.0×	882 0.9×	558 0.6×	399 1.2×	106	2.9k
Romain Boidot France	31	1.2k 1.0×	1.8k 1.5×	1.6k 1.6×	1.0k 1.2×	475 1.4×	112	4.0k
Nicholas Borcherding United States	28	773 0.6×	1.3k 1.1×	923 0.9×	467 0.5×	343 1.0×	77	2.7k
Phil F. Cheng Switzerland	29	827 0.7×	1.6k 1.3×	1.3k 1.2×	433 0.5×	281 0.8×	96	2.9k
Michael Hölzel Germany	33	1.3k 1.0×	2.2k 1.9×	1.7k 1.7×	588 0.7×	443 1.3×	96	4.3k
Su Yin Lim Australia	28	1.4k 1.1×	1.3k 1.1×	1.6k 1.6×	474 0.5×	415 1.2×	50	3.1k
Dayana B. Rivadeneira United States	17	802 0.6×	1.1k 0.9×	957 0.9×	714 0.8×	271 0.8×	26	2.3k
Yuliya Pylayeva‐Gupta United States	18	1.4k 1.1×	1.8k 1.5×	2.0k 2.0×	572 0.6×	255 0.7×	27	3.8k
Andrew Nguyen United States	19	1.2k 0.9×	972 0.8×	1.2k 1.2×	421 0.5×	384 1.1×	46	2.6k
Tiziana Triulzi Italy	30	713 0.6×	1.7k 1.4×	1.4k 1.4×	1.2k 1.3×	345 1.0×	61	3.3k

Countries citing papers authored by Peter J. Siska

Since Specialization

Citations

This map shows the geographic impact of Peter J. Siska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Siska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Siska more than expected).

Fields of papers citing papers by Peter J. Siska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Siska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Siska. The network helps show where Peter J. Siska may publish in the future.

Co-authorship network of co-authors of Peter J. Siska

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Siska. A scholar is included among the top collaborators of Peter J. Siska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Siska. Peter J. Siska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brummer, Christina, Sakhila Ghimire, Katrin Peter, et al.. (2025). Impact of Liver and Kidney Function on Vitamin D3 Metabolism in Female and Male Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation. International Journal of Molecular Sciences. 26(7). 2866–2866.

Benhamouda, Nadine, et al.. (2025). The CD70–CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target. Clinical Cancer Research. 31(14). 2872–2881. 2 indexed citations

Simeth, Jakob, Roman Mayr, Florian Weber, et al.. (2025). Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells. Translational Oncology. 61. 102513–102513.

Giudice, Francesco Del, Maximilian Haas, Emily Rinderknecht, et al.. (2025). Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival. Journal of Cachexia Sarcopenia and Muscle. 16(6). e70146–e70146.

Siska, Peter J., et al.. (2024). 'Living drugs' target CD70 in advanced renal tumors. Trends in Pharmacological Sciences. 45(9). 757–759. 3 indexed citations

Pichler, Renate, Peter J. Siska, Piotr Tymoszuk, et al.. (2023). A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. Frontiers in Immunology. 14. 1095195–1095195. 14 indexed citations

Lindner, Andrea Katharina, et al.. (2022). Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma. Frontiers in Oncology. 12. 906014–906014. 19 indexed citations

Contreras, Diana C., Jacqueline Cephus, Nowrin U. Chowdhury, et al.. (2021). Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation. The Journal of Immunology. 206(6). 1127–1139. 17 indexed citations

Beckermann, Kathryn E., Rachel A. Hongo, Xiang Ye, et al.. (2020). CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation. JCI Insight. 5(16). 72 indexed citations

10.

Spanier, Gerrit, Sandra Schmidhofer, Almut Brand, et al.. (2020). The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients. Cancer Letters. 499. 209–219. 9 indexed citations

11.

Peter, Katrin, Peter J. Siska, Tobias Roider, et al.. (2020). 1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation. Bone Marrow Transplantation. 56(2). 419–433. 9 indexed citations

12.

Singer, Katrin, Katja Dettmer, Petra Unger, et al.. (2019). Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis. Frontiers in Oncology. 9. 605–605. 22 indexed citations

13.

Greenplate, Allison R., Deon B. Doxie, Kirsten E. Diggins, et al.. (2018). Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types. Cancer Immunology Research. 7(1). 86–99. 21 indexed citations

14.

Zhao, Fei, Kathy S. Evans, Christine Xiao, et al.. (2018). Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma. Cancer Immunology Research. 6(12). 1459–1471. 91 indexed citations

15.

Ji, Xiangming, Jun Qian, S.M. Jamshedur Rahman, et al.. (2018). xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene. 37(36). 5007–5019. 253 indexed citations

16.

Renner, Kathrin, Peter J. Siska, Christina Brummer, et al.. (2018). Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Frontiers in Pharmacology. 9. 1258–1258. 13 indexed citations

17.

Siska, Peter J., Kathryn E. Beckermann, Frank M. Mason, et al.. (2017). Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight. 2(12). 274 indexed citations

18.

Renner, Kathrin, Katrin Singer, Gudrun E. Koehl, et al.. (2017). Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment. Frontiers in Immunology. 8. 248–248. 286 indexed citations

19.

Johnson, Marc O., Peter J. Siska, Diana C. Contreras, & Jeffrey C. Rathmell. (2016). Nutrients and the microenvironment to feed a T cell army. Seminars in Immunology. 28(5). 505–513. 53 indexed citations

20.

Siska, Peter J. & Jeffrey C. Rathmell. (2015). T cell metabolic fitness in antitumor immunity. Trends in Immunology. 36(4). 257–264. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact